Key points are not available for this paper at this time.
Targeting a cytokine on the surface of regulatory T cells inhibits their suppression of tumor cell killing by effector T cells.
Budhu et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: